1. Home
  2. BCAX
  3. BCAX News

Latest BICARA THERAPEUTICS INC (BCAX) News on January 19, 2025

Early success for MBX in Phase I trial of GLP-1RA for hypoglycaemia
BCAX

Clinical Trials Arena

11 days ago

Early success for MBX in Phase I trial of GLP-1RA for hypoglycaemia

BCAX

MT Newswires

2 months ago

Bicara Therapeutics' Q3 Loss Narrows

Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
BCAX

GlobeNewswire

2 months ago

Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference
BCAX

GlobeNewswire

2 months ago

Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference

Opening Day: Another trio of biotech IPOs make Friday debut
BCAX

TipRanks

3 months ago

Opening Day: Another trio of biotech IPOs make Friday debut

BCAX

Investing.com

3 months ago

MBX Biosciences earns Buy rating at three investment firms

BCAX

GuruFocus.com

4 months ago

RA Capital Management's Strategic Acquisition of Bicara Therapeutics Shares

TPG GP A, LLC Acquires New Stake in Bicara Therapeutics Inc
BCAX

GuruFocus.com

4 months ago

TPG GP A, LLC Acquires New Stake in Bicara Therapeutics Inc

FMR LLC Acquires New Stake in Bicara Therapeutics Inc
BCAX

GuruFocus.com

4 months ago

FMR LLC Acquires New Stake in Bicara Therapeutics Inc

BCAX

MT Newswires

4 months ago

Bicara Therapeutics Insider Bought Shares Worth $1,260,000, According to a Recent SEC Filing

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity
BCAX

Pharmaceutical Technology

4 months ago

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity

BCAX

MT Newswires

4 months ago

MBX Biosciences Closes Upsized IPO

BCAX

MT Newswires

4 months ago

Bicara Therapeutics Closes $362 Million IPO

Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
BCAX

GlobeNewswire

4 months ago

Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share on Social Networks: